Want to see IN:DIAMINESQ full AI Analyst Report?
Top Page
Diamines & Chemicals Ltd.
(DIAMINESQ)
Select Model
Select Model
Rating:44Neutral
Price Target:
₹233.00
▼(-2.96% Downside)
Action:Reiterated
Date:08/23/26
The score is held down primarily by weak financial performance—FY2026 losses, a steep revenue decline, and sustained negative operating/free cash flow—despite a relatively supportive balance sheet. Technicals also remain soft with price below key moving averages and a negative MACD. Valuation offers limited offset since the negative P/E reflects current losses and the dividend yield is modest.
Positive Factors
Balance Sheet Strength
A substantial equity buffer and historically low leverage provide resilience through the downturn. This can help the company fund operations, absorb cyclical volatility, and pursue recovery without immediate dependence on heavy external borrowing.
Negative Factors
Revenue and Profit Collapse
The sharp revenue contraction and swing into substantial losses weaken earnings quality and visibility. Unless sales recover, fixed costs and lower operating leverage can continue suppressing margins, making a durable return to prior profitability uncertain.
Read all positive and negative factors
Positive Factors
Negative Factors
Balance Sheet Strength
A substantial equity buffer and historically low leverage provide resilience through the downturn. This can help the company fund operations, absorb cyclical volatility, and pursue recovery without immediate dependence on heavy external borrowing.
Read all positive factors
Diamines & Chemicals Ltd. (DIAMINESQ) vs. iShares MSCI India ETF (INDA)
Market Cap
₹2.63B
Dividend Yield0.38%
Average Volume (3M)2.29K
Price to Earnings (P/E)―
Beta (1Y)0.76
Revenue Growth-39.30%
EPS Growth-700.73%
CountryIN
Employees131
SectorGeneral
Sector StrengthN/A
IndustryChemicals
Share Statistics
EPS (TTM)-10.22
Shares Outstanding10,053,392
10 Day Avg. Volume1,210
30 Day Avg. Volume2,294
Financial Highlights & Ratios
PEG Ratio0.03
Price to Book (P/B)1.45
Price to Sales (P/S)5.93
P/FCF Ratio-7.74
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
EPS Forecast (FY)N/A
Revenue Forecast (FY)N/A
Diamines & Chemicals Ltd. Business Overview & Revenue Model
Company Description
Diamines and Chemicals Limited engages in the manufacture and marketing of organic chemical compounds in India. It operates in two segments, Specialty Chemicals, and Trading in Fruits and Vegetables. The company's products include piperazine anhyd...
How the Company Makes Money
null...
Diamines & Chemicals Ltd. Financial Statement Overview
Summary
Income Statement
32
Negative
Balance Sheet
78
Positive
Cash Flow
24
Negative
| Breakdown | TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 |
|---|---|---|---|---|---|---|
Income Statement | ||||||
| Total Revenue | 411.11M | 384.79M | 714.72M | 1.03B | 1.10B | 658.90M |
| Gross Profit | 66.99M | 23.65M | 353.88M | 444.26M | 737.89M | 375.84M |
| EBITDA | -83.23M | -138.05M | 86.12M | 251.30M | 581.54M | 237.95M |
| Net Income | -100.72M | -127.83M | 27.31M | 154.71M | 419.04M | 167.14M |
Balance Sheet | ||||||
| Total Assets | 0.00 | 1.74B | 1.78B | 1.63B | 1.51B | 1.11B |
| Cash, Cash Equivalents and Short-Term Investments | 327.46M | 320.69M | 413.96M | 362.95M | 248.05M | 390.90M |
| Total Debt | 0.00 | 81.86M | 251.00K | 0.00 | 0.00 | 0.00 |
| Total Liabilities | -1.57B | 169.43M | 168.31M | 145.62M | 165.51M | 103.56M |
| Stockholders Equity | 1.57B | 1.57B | 1.61B | 1.48B | 1.35B | 1.00B |
Cash Flow | ||||||
| Free Cash Flow | -199.95M | -294.49M | -90.37M | 132.88M | -70.06M | 123.03M |
| Operating Cash Flow | -71.15M | -80.98M | -50.22M | 218.96M | 162.85M | 272.74M |
| Investing Cash Flow | -108.41M | -319.91M | 146.54M | -188.33M | -86.63M | -214.91M |
| Financing Cash Flow | 87.33M | 183.35M | 97.47M | -31.29M | -60.15M | -52.80M |
Diamines & Chemicals Ltd. Peers Comparison
UnderperformOutperform
Sector (55)
Name | Overall Rating | Market Cap | P/E Ratio | ROE | Dividend Yield | Revenue Growth | EPS Growth |
|---|---|---|---|---|---|---|---|
67 Neutral | ₹9.21B | 11.43 | ― | 0.39% | 13.23% | 22.22% | |
59 Neutral | ₹7.18B | 17.94 | ― | 0.86% | 49.58% | 43.22% | |
56 Neutral | ₹11.06B | 20.54 | ― | 0.99% | 1.41% | 946.41% | |
55 Neutral | $6.65B | 3.83 | -15.92% | 6.20% | 10.91% | 7.18% | |
54 Neutral | ₹216.47B | 27.65 | ― | 0.47% | 8.20% | 29.06% | |
52 Neutral | ₹7.43B | 12.94 | ― | 0.77% | -22.78% | ― | |
44 Neutral | ₹2.63B | -25.27 | ― | 0.38% | -39.30% | -700.73% |
* General Sector Average
IN:DIAMINESQ
Diamines & Chemicals Ltd.
261.30
-97.35
-27.14%
IN:DEEPAKNTR
Deepak Nitrite Limited
1,587.10
-152.06
-8.74%
IN:DMCC
DMCC Speciality Chemicals Limited
288.05
-11.17
-3.73%
IN:INDOAMIN
Indo Amines Limited
126.85
-16.75
-11.66%
IN:KANORICHEM
Kanoria Chemicals & Industries Ltd
170.00
84.44
98.69%
IN:VALIANTORG
Valiant Organics Limited
394.40
24.85
6.72%
Diamines & Chemicals Ltd. Corporate Events
Diamines & Chemicals Boosts Subsidiary Investment and Streamlines Operations
Aug 5, 2026
Diamines Chemicals Ltd. has approved its standalone and consolidated unaudited financial results for the quarter ended June 30, 2026, while also committing an additional Rs. 40 crore investment in its wholly owned subsidiary to fund long-term cap...
Glossary
BuyA stock rated as a "Buy" is expected to perform better than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock is likely to deliver higher returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
HoldA stock rated as a "Hold" is expected to perform in line with the overall market or a specific benchmark. This rating indicates that the stock is neither particularly compelling nor unfavorable for investment. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
SellA stock rated as a "Sell" is expected to perform worse than the overall market or a specific benchmark over the near-to-medium term. This rating suggests the stock may deliver lower returns compared to other stocks in the same sector or market index. Note: This is not investment advice; please consult a financial advisor before making investment decisions.
Disclaimer
This AI Analyst Stock Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in stocks carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.